Vidac Pharma

U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates

19 September 2024 -- London, UK -- Vidac Pharma Holdings Plc, a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces that the United States Patent and Trademark Office (USPTO) has issued a patent to the company offering broad protection of the mode of action underlying its oncology and onco-dermatologic therapeutic candidates....
Vidac Pharma Holding PLC, Dr. Max Herzberg, 20-22 Wenlock Road, London N1 7GU, United Kingdom

+972-54-4257381